Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Meet The Attys For Humana In Price-Fixing MDL Set For Trial No Photo Available

Gianna Ferrarin

Attorneys from Lowey Dannenberg PC and Schneider Wallace Cottrell Kim LLP are teaming up to represent insurance giant Humana in the fi... (more story)

Lax Enforcement Spurs Suits Over Insurers' 'Ghost' Networks No Photo Available

Hannah Albarazi

More patients are alleging that what are known as insurers' ghost networks — directories full of unreachable providers — deny them acc... (more story)

Vax Critic Atty Wants To 'Depoliticize' Shots No Photo Available

Yeji Jesse Lee

Attorney Aaron Siri, who specializes in vaccine cases and has close ties to Health and Human Services Secretary Robert F. Kennedy Jr.,... (more story)